- Filed
- May 12, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2023 · May 9, 2023 | 7.38M sh |
| Shares Diluted | Q1 2023 · Mar 31, 2023 | 7.32M sh |
| Shares Diluted restated | Q1 2023 · Mar 31, 2022 | 3.58M sh |
| Operating Cash Flow | Q1 2023 · Mar 31, 2023 | −$5.08M |
| Operating Cash Flow | Q1 2023 · Mar 31, 2022 | −$6.04M |
| Cash And Equivalents | Q1 2023 · Mar 31, 2023 | $6.39M |
| Cash And Equivalents | Q1 2023 · Dec 31, 2022 | $11.45M |
| Stockholders Equity | Q1 2023 · Mar 31, 2023 | $12.42M |
| Stockholders Equity | Q1 2023 · Dec 31, 2022 | $16.62M |
| Stockholders Equity | Q1 2023 · Mar 31, 2022 | $17.79M |
| Stockholders Equity | Q1 2023 · Dec 31, 2021 | $19.24M |
| Current Liabilities | Q1 2023 · Mar 31, 2023 | $2.17M |
| Current Liabilities | Q1 2023 · Dec 31, 2022 | $2.07M |
| Total Liabilities | Q1 2023 · Mar 31, 2023 | $5.63M |
| Total Liabilities | Q1 2023 · Dec 31, 2022 | $6.23M |
| Current Assets | Q1 2023 · Mar 31, 2023 | $8.93M |
| Current Assets | Q1 2023 · Dec 31, 2022 | $13.26M |
| Total Assets | Q1 2023 · Mar 31, 2023 | $18.05M |
| Total Assets | Q1 2023 · Dec 31, 2022 | $22.85M |
| Eps Diluted | Q1 2023 · Mar 31, 2023 | −$0.58 |
| Eps Diluted restated | Q1 2023 · Mar 31, 2022 | −$2.37 |
| Eps Basic | Q1 2023 · Mar 31, 2023 | −$0.58 |
| Eps Basic restated | Q1 2023 · Mar 31, 2022 | −$1.12 |
| Rd Expense | Q1 2023 · Mar 31, 2023 | $2.28M |
| Rd Expense | Q1 2023 · Mar 31, 2022 | $2.86M |
| Rd Expense | Q1 2023 · Jun 25, 2021 | $6.5M |
| Net Income | Q1 2023 · Mar 31, 2023 | −$4.24M |
| Net Income | Q1 2023 · Mar 31, 2022 | −$3.77M |
| Operating Income | Q1 2023 · Mar 31, 2023 | −$4.8M |
| Operating Income | Q1 2023 · Mar 31, 2022 | −$8.87M |
| Capex | Q1 2023 · Mar 31, 2022 | $31K |
| Gross Profit | Q1 2023 · Mar 31, 2022 | $250K |
| Revenue | Q1 2023 · Mar 31, 2022 | $741K |